close

Cutera, Inc., a medical device company, engages in designing, developing, manufacturing, marketing, and servicing laser and other light-based aesthetics systems for practitioners worldwide. It offers products based on three platforms: CoolGlide, Xeo, and Solera, which enable physicians and other qualified practitioners to perform aesthetic procedures. The CoolGlide product platform offers laser applications for hair removal; the treatment of a range of vascular lesions, including leg and facial veins; and Laser Genesis, a skin rejuvenation procedure that reduces fine lines, and reduces pore size and improves skin texture. The Xeo platform can combine pulsed light and laser applications in a single system, enable in removing unwanted hair, treating vascular lesions, and rejuvenating the skin by treating discoloration, improving texture, reducing pore size, and treating fine lines and laxity. The Solera platform, which is a compact tabletop system to support a single technology platform that uses infrared (Solera Titan) or pulsed light (Solera Opus), and is used to remove unwanted hair, treat vascular lesions, and rejuvenate the skin. The company sells its products through direct sales force and distributors to dermatologists, plastic surgeons, gynecologists, family practitioners, primary care physicians, physicians offering aesthetic treatments in non-medical offices, and other qualified practitioners. Cutera, Inc. was founded in 1998 and is headquartered in Brisbane, California.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	9.30
Volume	37849
Volume Avg	65057
52 Week High	9.90
52 Week Low	6.75
PE	N/A
PE (group average)	39
EPS Year	-0.77
EPS change Q/Q	-211.11%
EPS change Q/Q Yr ago	-86.67%
EPS change Q/Q next Q est	-180%
EPS change Y/Y	-48.89%
REV change Q/Q	-23.68%
REV change Q/Q Yr ago	-15.33%
EPS next Q est	-0.10
EPS next Y est	-0.14
Divident Annual	0.00
Dividend Yield	0%